TRAVASOL
Google image searchProduct monograph
Active ingredients
phenylalanine, 560 MG/100 ML
methionine, 400 MG/100 ML
l-lysine (l-lysine hydrochloride), 580 MG/100 ML
isoleucine, 600 MG/100 ML
valine, 580 MG/100 ML
histidine, 480 MG/100 ML
threonine, 420 MG/100 ML
tryptophan, 180 MG/100 ML
l-alanine, 2.07 G/100 ML
glycine, 1.03 G/100 ML
arginine, 1.15 G/100 ML
proline, 680 MG/100 ML
tyrosine, 40 MG/100 ML
serine, 500 MG/100 ML
leucine, 730 MG/100 ML
DIN: 00872296
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: BLEND C
Schedule: Ethical
Company: BAXTER CORPORATION
Date: 16-OCT-2013
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05B — I.V. SOLUTIONS (ATC, ATC/DDD)
- B05BA — Solutions for parenteral nutrition (ATC, ATC/DDD)
- B05BA01 — AMINO ACIDS (ATC/DDD)
Pharmaceutical standard: MFR
External Links for Travasol
Search on Google
- Travasol side effects
- Travasol dosage
- phenylalanine side effects
- phenylalanine dosage
- methionine side effects
- methionine dosage
- l-lysine side effects
- l-lysine dosage
- isoleucine side effects
- isoleucine dosage
- valine side effects
- valine dosage
- histidine side effects
- histidine dosage
- threonine side effects
- threonine dosage
- tryptophan side effects
- tryptophan dosage
- l-alanine side effects
- l-alanine dosage
- glycine side effects
- glycine dosage
- arginine side effects
- arginine dosage
- proline side effects
- proline dosage
- tyrosine side effects
- tyrosine dosage
- serine side effects
- serine dosage
- leucine side effects
- leucine dosage
